222 related articles for article (PubMed ID: 37198153)
21. Functional variant analyses (FVAs) predict pathogenicity in the BRCA1 DNA double-strand break repair pathway.
Loke J; Pearlman A; Upadhyay K; Tesfa L; Shao Y; Ostrer H
Hum Mol Genet; 2015 Jun; 24(11):3030-7. PubMed ID: 25652403
[TBL] [Abstract][Full Text] [Related]
22. Targeting the DNA repair defect of BRCA tumours.
Turner N; Tutt A; Ashworth A
Curr Opin Pharmacol; 2005 Aug; 5(4):388-93. PubMed ID: 15955736
[TBL] [Abstract][Full Text] [Related]
23. EXO1 protects BRCA1-deficient cells against toxic DNA lesions.
van de Kooij B; Schreuder A; Pavani R; Garzero V; Uruci S; Wendel TJ; van Hoeck A; San Martin Alonso M; Everts M; Koerse D; Callen E; Boom J; Mei H; Cuppen E; Luijsterburg MS; van Vugt MATM; Nussenzweig A; van Attikum H; Noordermeer SM
Mol Cell; 2024 Feb; 84(4):659-674.e7. PubMed ID: 38266640
[TBL] [Abstract][Full Text] [Related]
24. DNA damage response markers are differentially expressed in BRCA-mutated breast cancers.
Aleskandarany M; Caracappa D; Nolan CC; Macmillan RD; Ellis IO; Rakha EA; Green AR
Breast Cancer Res Treat; 2015 Feb; 150(1):81-90. PubMed ID: 25690937
[TBL] [Abstract][Full Text] [Related]
25. The biological effects and clinical implications of BRCA mutations: where do we go from here?
Stoppa-Lyonnet D
Eur J Hum Genet; 2016 Sep; 24 Suppl 1(Suppl 1):S3-9. PubMed ID: 27514841
[TBL] [Abstract][Full Text] [Related]
26. Clinical efficacy of PARP inhibitors in breast cancer.
Pandya K; Scher A; Omene C; Ganesan S; Kumar S; Ohri N; Potdevin L; Haffty B; Toppmeyer DL; George MA
Breast Cancer Res Treat; 2023 Jul; 200(1):15-22. PubMed ID: 37129747
[TBL] [Abstract][Full Text] [Related]
27. The relationship between the roles of BRCA genes in DNA repair and cancer predisposition.
Tutt A; Ashworth A
Trends Mol Med; 2002 Dec; 8(12):571-6. PubMed ID: 12470990
[TBL] [Abstract][Full Text] [Related]
28. Chromosomal mutagen sensitivity associated with mutations in BRCA genes.
Speit G; Trenz K
Cytogenet Genome Res; 2004; 104(1-4):325-32. PubMed ID: 15162060
[TBL] [Abstract][Full Text] [Related]
29. Diverse
Weigelt B; Comino-Méndez I; de Bruijn I; Tian L; Meisel JL; García-Murillas I; Fribbens C; Cutts R; Martelotto LG; Ng CKY; Lim RS; Selenica P; Piscuoglio S; Aghajanian C; Norton L; Murali R; Hyman DM; Borsu L; Arcila ME; Konner J; Reis-Filho JS; Greenberg RA; Robson ME; Turner NC
Clin Cancer Res; 2017 Nov; 23(21):6708-6720. PubMed ID: 28765325
[No Abstract] [Full Text] [Related]
30. Genomic scars as biomarkers of homologous recombination deficiency and drug response in breast and ovarian cancers.
Watkins JA; Irshad S; Grigoriadis A; Tutt AN
Breast Cancer Res; 2014 Jun; 16(3):211. PubMed ID: 25093514
[TBL] [Abstract][Full Text] [Related]
31. Age-associated deficient recruitment of 53BP1 in G1 cells directs DNA double-strand break repair to BRCA1/CtIP-mediated DNA-end resection.
Anglada T; Genescà A; Martín M
Aging (Albany NY); 2020 Dec; 12(24):24872-24893. PubMed ID: 33361520
[TBL] [Abstract][Full Text] [Related]
32. Breast Cancer Predisposition Genes and Synthetic Lethality.
Neiger HE; Siegler EL; Shi Y
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070674
[No Abstract] [Full Text] [Related]
33. PALB2 functionally connects the breast cancer susceptibility proteins BRCA1 and BRCA2.
Zhang F; Fan Q; Ren K; Andreassen PR
Mol Cancer Res; 2009 Jul; 7(7):1110-8. PubMed ID: 19584259
[TBL] [Abstract][Full Text] [Related]
34. BRCA1 regulates RAD51 function in response to DNA damage and suppresses spontaneous sister chromatid replication slippage: implications for sister chromatid cohesion, genome stability, and carcinogenesis.
Cousineau I; Abaji C; Belmaaza A
Cancer Res; 2005 Dec; 65(24):11384-91. PubMed ID: 16357146
[TBL] [Abstract][Full Text] [Related]
35. Homologous recombination and human health: the roles of BRCA1, BRCA2, and associated proteins.
Prakash R; Zhang Y; Feng W; Jasin M
Cold Spring Harb Perspect Biol; 2015 Apr; 7(4):a016600. PubMed ID: 25833843
[TBL] [Abstract][Full Text] [Related]
36. Nonhomologous end-joining of ionizing radiation-induced DNA double-stranded breaks in human tumor cells deficient in BRCA1 or BRCA2.
Wang H; Zeng ZC; Bui TA; DiBiase SJ; Qin W; Xia F; Powell SN; Iliakis G
Cancer Res; 2001 Jan; 61(1):270-7. PubMed ID: 11196174
[TBL] [Abstract][Full Text] [Related]
37. Interaction of Wwox with Brca1 and associated complex proteins prevents premature resection at double-strand breaks and aberrant homologous recombination.
Park D; Gharghabi M; Schrock MS; Plow R; Druck T; Yungvirt C; Aldaz CM; Huebner K
DNA Repair (Amst); 2022 Feb; 110():103264. PubMed ID: 34998176
[TBL] [Abstract][Full Text] [Related]
38. Minding the gap: the underground functions of BRCA1 and BRCA2 at stalled replication forks.
Nagaraju G; Scully R
DNA Repair (Amst); 2007 Jul; 6(7):1018-31. PubMed ID: 17379580
[TBL] [Abstract][Full Text] [Related]
39. Use of DNA-damaging agents and RNA pooling to assess expression profiles associated with BRCA1 and BRCA2 mutation status in familial breast cancer patients.
Walker LC; Thompson BA; Waddell N; ; Grimmond SM; Spurdle AB
PLoS Genet; 2010 Feb; 6(2):e1000850. PubMed ID: 20174566
[TBL] [Abstract][Full Text] [Related]
40. The Novel Ribonucleotide Reductase Inhibitor COH29 Inhibits DNA Repair In Vitro.
Chen MC; Zhou B; Zhang K; Yuan YC; Un F; Hu S; Chou CM; Chen CH; Wu J; Wang Y; Liu X; Smith DL; Li H; Liu Z; Warden CD; Su L; Malkas LH; Chung YM; Hu MC; Yen Y
Mol Pharmacol; 2015 Jun; 87(6):996-1005. PubMed ID: 25814515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
